Showing results (41-50 of 148) with videos related to
Sort By:
Pageof 15
Journal of Diabetes Research|August 18, 2018
Insulin Adherence in Type 2 Diabetes in Mexico: Behaviors and BarriersJanneth Bermeo-Cabrera, Paloma Almeda-Valdes, Josefa Riofrios-Palacios, et al.Current Diabetes Reviews|December 26, 2009
UKPDS Risk Engine, decode and diabetes PHD models for the estimation of cardiovascular risk in patients with diabetesPaloma Almeda-Valdes, Daniel Cuevas-Ramos, Roopa Mehta, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 24, 2007
Analysis of fasting plasma glucose values for optimal detection of abnormal responses on the oral glucose tolerance test in at-risk study subjectsLudivina Robles-Osorio, Carlos A Aguilar-Salinas, Roopa Mehta, et al.Current Diabetes Reviews|February 8, 2011
Management of type 2 diabetes: more evidence is required to address the clinical and contextual facetsSergio Hernandez-Jimenez, Carlos A Aguilar-Salinas, Roopa Mehta, et al.American Journal of Preventive Cardiology|December 3, 2024
Lipoprotein(a) throughout life in womenPablo Corral, María Gabriela Matta, Carlos Aguilar-Salinas, et al.Cardiovascular Diabetology|April 26, 2008
Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study)Michel Komajda, Paula Curtis, Markolf Hanefeld, et al.Diabetes Care|March 21, 2025
The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 DiabetesGeremia B Bolli, Philip D Home, Francesca Porcellati, et al.Diabetes, Obesity & Metabolism|July 7, 2020
Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists: a systematic literature review and indirect treatment comparisonPhilip D Home, Vanita R Aroda, Lawrence Blonde, et al.The New England Journal of Medicine|June 7, 2007
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysisPhilip D Home, Stuart J Pocock, Henning Beck-Nielsen, et al.Current Diabetes Reviews|January 29, 2008
Management of the metabolic syndrome as a strategy for preventing the macrovascular complications of type 2 diabetes: controversial issuesCarlos A Aguilar-Salinas, Roopa Mehta, Rosalba Rojas, et al.Pageof 15